Literature DB >> 23291524

[Antibiotic prophylaxis for surgical wound infection in cardiac surgery: results of a Spanish survey].

J Izquierdo-Blasco1, P Soler-Palacín, M Campins-Martí, J L Vázquez Martínez, J Sanchez-de-Toledo.   

Abstract

INTRODUCTION: No Spanish guidelines for the prevention of surgical wound infection in paediatric cardiac surgery are currently available. The aim of this study was to analyse the nationwide variability in antibiotic prophylaxis use.
MATERIAL AND METHODS: An online questionnaire was distributed to all members of the Cardiology Group of the Spanish Society of Paediatric Intensive Care. Fifteen centres participated in the study.
RESULTS: In heart surgery with no delayed sternal closure, all 15 centres used a 1st or 2nd generation cephalosporin in paediatric patients, while 3 hospitals used a broader-spectrum antibiotic therapy in neonates. Prophylaxis was maintained for 12-72h in 11 centres and until drainage removal in four. Thirteen centres used delayed sternal closure, eight of which followed the same protocol for these patients as for standard procedures. Prophylaxis was maintained for 12-72h in 6 centres, and until sternal closure at the rest. Five out of 10 centres performing extracorporeal membrane oxygenation (ECMO) maintained the same antibiotic protocol as in standard surgery.
CONCLUSIONS: A wide variability was observed in antibiotic prophylaxis use in high-risk patients. Thus, national protocols need to be standardised.
Copyright © 2012 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23291524     DOI: 10.1016/j.anpedi.2012.11.018

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  1 in total

1.  Impact of the implementation of an interdisciplinary infection control program to prevent surgical wound infection in pediatric heart surgery.

Authors:  Jaume Izquierdo-Blasco; Magda Campins-Martí; Pere Soler-Palacín; Joan Balcells; Raul Abella; Ferran Gran; Félix Castillo; Rosario Nuño; Joan Sanchez-de-Toledo
Journal:  Eur J Pediatr       Date:  2015-02-05       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.